器官發生控股公司
DE ˙ DB ˙ US68621F1021
€2.08 ↑0.09 (4.52%)
2026-06-04
分享價格
SecurityDE:2PQ / Organogenesis Holdings Inc.
InstitutionBarclays Plc
Latest Disclosed Ownership106,407 shares
Latest Disclosed Value $ 551,187
Barclays Plc reports 8.90% increase in ownership of 2PQ / Organogenesis Holdings Inc.

On February 13, 2026 - Barclays Plc filed a 13F-HR form disclosing ownership of 106,407 shares of Organogenesis Holdings Inc. (DE:2PQ) valued at $463,935 USD as of December 31, 2025. The entity filed a previous 13F-HR/A on March 31, 2026 disclosing 97,710 shares of Organogenesis Holdings Inc.. This represents a change in shares of 8.90% during the quarter. The current value of the position is $221,327 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-02-13 2025-12-31 13F ORGANOGENESIS HLDGS COM 68621F102 106,407 8,697 8.90 551 33.74 0.0001
2026-03-31 2025-09-30 13F/A-3 ORGANOGENESIS HLDGS COM 68621F102 97,710 -24,842 -20.27 412 -8.04 0.0001
2026-03-19 2025-09-30 13F/A-2 ORGANOGENESIS HLDGS COM 68621F102 94,809 -27,743 271 0.0001
2025-11-12 2025-09-30 13F ORGANOGENESIS HLDGS COM 68621F102 97,710 -24,842 412 0.0001
2026-02-27 2025-06-30 13F/A-2 ORGANOGENESIS HLDGS COM 68621F102 122,552 32,403 35.94 449 15.17 0.0001
2025-08-14 2025-06-30 13F/A-1 ORGANOGENESIS HLDGS COM 68621F102 122,552 32,403 0 0.0001
2025-08-13 2025-06-30 13F ORGANOGENESIS HLDGS COM 68621F102 122,552 32,403 0 0.0000
2026-03-17 2025-03-31 13F/A-1 ORGANOGENESIS HLDGS COM 68621F102 90,149 -20,766 -18.72 389 9.89 0.0001
2025-05-15 2025-03-31 13F ORGANOGENESIS HLDGS COM 68621F102 90,149 -20,766 0 0.0001
2026-03-19 2024-12-31 13F/A-1 ORGANOGENESIS HLDGS COM 68621F102 110,915 16,106 16.99 355 30.63 0.0001
2025-02-13 2024-12-31 13F ORGANOGENESIS HLDGS COM 68621F102 110,915 16,106 0 0.0001
2026-03-31 2024-09-30 13F/A-2 ORGANOGENESIS HLDGS COM 68621F102 94,809 67,855 251.74 271 261.33 0.0001
2024-11-19 2024-09-30 13F/A-1 ORGANOGENESIS HLDGS COM 68621F102 94,809 67,855 0 0.0001
2024-11-15 2024-09-30 13F ORGANOGENESIS HLDGS COM 68621F102 94,809 67,855 0 0.0000
2026-03-23 2024-06-30 13F/A-1 ORGANOGENESIS HLDGS COM 68621F102 26,954 -22,306 -45.28 75 -46.04 0.0000
2024-08-14 2024-06-30 13F ORGANOGENESIS HLDGS COM 68621F102 26,954 -22,306 0 0.0000
2026-03-24 2024-03-31 13F/A-1 ORGANOGENESIS HLDGS COM 68621F102 49,260 -46,942 -48.80 140 -64.63 0.0000
2024-05-15 2024-03-31 13F ORGANOGENESIS HLDGS COM 68621F102 49,260 -46,942 0 0.0000
2026-03-25 2023-12-31 13F/A-1 ORGANOGENESIS HLDGS COM 68621F102 96,202 70,926 280.61 393 391.25 0.0001
2024-02-15 2023-12-31 13F ORGANOGENESIS HLDGS COM 68621F102 96,202 70,926 0 0.0001
2026-03-26 2023-09-30 13F/A-1 ORGANOGENESIS HLDGS COM 68621F102 25,276 11,284 80.65 80 73.91 0.0001
2023-11-07 2023-09-30 13F ORGANOGENESIS HLDGS COM 68621F102 25,276 11,284 0 0.0000
2026-03-30 2023-06-30 13F/A-2 ORGANOGENESIS HLDGS COM 68621F102 13,992 -88,836 -86.39 46 -79.00 0.0000
2023-09-20 2023-06-30 13F/A-1 ORGANOGENESIS HLDGS COM 68621F102 13,992 -88,836 0 0.0000
2023-08-03 2023-06-30 13F ORGANOGENESIS HLDGS COM 68621F102 13,992 -88,836 0 0.0000
2026-03-30 2023-03-31 13F/A-1 ORGANOGENESIS HLDGS COM 68621F102 102,828 -3,963 -3.71 219 -23.69 0.0001
2023-05-04 2023-03-31 13F ORGANOGENESIS HLDGS COM 68621F102 102,828 -3,963 0 0.0001
2026-03-30 2022-12-31 13F/A-1 ORGANOGENESIS HLDGS COM 68621F102 106,791 67,203 169.76 287 122.48 0.0001
2023-02-13 2022-12-31 13F ORGANOGENESIS HLDGS COM 68621F102 106,791 67,203 0 0.0001
2022-11-03 2022-09-30 13F ORGANOGENESIS HLDGS COM 68621F102 39,588 19,548 97.54 129 31.63 0.0001
2022-08-12 2022-06-30 13F ORGANOGENESIS HLDGS COM 68621F102 20,040 -32,041 -61.52 98 -75.31 0.0001
2022-05-16 2022-03-31 13F ORGANOGENESIS HLDGS COM 68621F102 52,081 -6,582 -11.22 397 -26.89 0.0003
2022-02-23 2021-12-31 13F/A-1 ORGANOGENESIS HLDGS COM 68621F102 58,663 9,766 19.97 543 -21.98 0.0002
2022-02-14 2021-12-31 13F ORGANOGENESIS HLDGS COM 68621F102 58,663 9,766 543 0.0001
2021-11-09 2021-09-30 13F ORGANOGENESIS HLDGS COM 68621F102 48,897 11,311 30.09 696 11.18 0.0003
2021-08-13 2021-06-30 13F ORGANOGENESIS HLDGS COM 68621F102 37,586 14,941 65.98 626 51.57 0.0003
2021-05-13 2021-03-31 13F ORGANOGENESIS HLDGS COM 68621F102 22,645 9,503 72.31 413 317.17 0.0002
2021-02-11 2020-12-31 13F ORGANOGENESIS HLDGS COM 68621F102 13,142 -1,458 -9.99 99 76.79 0.0001
2020-11-12 2020-09-30 13F ORGANOGENESIS HLDGS COM 68621F102 14,600 -1,847 -11.23 56 -12.50 0.0000
2020-08-12 2020-06-30 13F ORGANOGENESIS HLDGS COM 68621F102 16,447 7,151 76.93 64 113.33 0.0000
2020-05-13 2020-03-31 13F ORGANOGENESIS HLDGS COM 68621F102 9,296 -7,028 -43.05 30 -62.03 0.0000
2020-02-10 2019-12-31 13F ORGANOGENESIS HLDGS COM 68621F102 16,324 11,130 214.29 79 132.35 0.0000
2019-11-15 2019-09-30 13F/A-1 ORGANOGENESIS HLDGS COM 68621F102 5,194 -1,597 -23.52 34 -34.62 0.0000
2019-11-14 2019-09-30 13F ORGANOGENESIS HLDGS COM 68621F102 5,194 -1,597 34 7.8608
2019-08-14 2019-06-30 13F ORGANOGENESIS HLDGS COM 68621F102 6,791 -4,038 -37.29 52 -35.80 0.0000
2019-05-15 2019-03-31 13F ORGANOGENESIS HLDGS COM 68621F102 10,829 10,829 81 0.0001
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.